Intensivmedizin up2date, Table of Contents Intensivmedizin up2date 2016; 12(02): 159-174DOI: 10.1055/s-0041-110072 Allgemeine Prinzipien der Intensivmedizin © Georg Thieme Verlag KG Stuttgart · New York Intensivpflichtige Virusinfektionen der unteren Atemwege Nora Drick , Tobias Welte Recommend Article Abstract All articles of this category Full Text References Literatur 1 Luyt CE. Virus diseases in ICU patients: a long time underestimated; but be aware of overestimation. Intensive Care Med 2006; 32: 968-970 2 Lieberman D, Lieberman D, Gelfer Y et al. Pneumonic vs nonpneumonic acute exazerbations of COPD. Chest 2002; 122: 1264-1270 3 Atmar RL, Guy E, Guntupalli KK et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998; 158: 2453-2459 4 de Roux A, Marcos MA, Garcia E et al. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest 2004; 125: 1343-1351 5 Glezen WP, Greenberg SB, Atmar RL et al. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000; 283: 499-505 6 Herold S, Becker C, Ridge KM et al. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 2015; 45: 1463-1478 7 Choi SH, Hong SB, Ko GB et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012; 186: 325-332 8 Hong HL, Hong SB, Ko GB et al. Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One 2014; 9: e95865 9 Daubin C, Parienti JJ, Vincent S et al. Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study. Crit Care 2006; 10: R142 10 Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186 11 Robert Koch Institut. Aktualisierung der der Influenza zugeschriebenen Mortalität bis einschließlich der Saison 2012/2013. Epid Bull 2015; 3: 1-8 12 Catania J, Que LG, Govert JA et al. High Intensive Care Unit Admission Rate for 2013–2014 Influenza Is Associated with a Low Rate of Vaccination. Am J Respir Crit Care Med 2014; 189: 485-487 13 Paddock CD, Liu L, Denison AM et al. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012; 205: 895-905 14 Robert Koch Institut. Ratgeber für Ärzte: Influenza (Saisonale Influenza, Influenza A(H1N1) 2009, Aviäre Influenza). Stand 12/2013 15 Robert Koch Institut. Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: August 2014. Epid Bull 2014; 34: 305-340 16 Carrat F, Vergu E, Ferguson NM et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167: 775-785 17 Memoli MJ, Athota R, Reed S et al. The natural history of influenza infection in the severly immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 2014; 58: 214 18 Jefferson T, Jones M, Doshi P et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014; 348: g2545 19 Dobson J, Whitley RJ, Pocock S et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015; 385: 1729-1737 20 Muthuri SG, Venkatesan S, Myles PR et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014; 2: 395-404 21 Martin-Loeches I, Lisboa T, Rhodes A et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011; 37: 272-283 22 Brun-Buisson C, Richard JC, Mercat A et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183: 1200-1206 23 Lee N, Lui GC, Wong KT et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 2013; 57: 1069-1077 24 McColl MD, Corser RB, Bremner J et al. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin. Bone Marrow Transplant 1998; 21: 423-425 25 Kumar D, Erdman D, Keshavjee S et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5: 2031-2036 26 Fuehner T, Dierich M, Duesberg C et al. Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections. Antivir Ther 2011; 16: 733-740 27 de Fontbrune FS, Robin M, Porcher R et al. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2007; 45: 1019-1024 28 Boivin G, Abed Y, Pelletier G et al. Virological features and clinical manifestations associated with human metapneumovirus: A new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002; 186: 1330-1334 29 Sumino KC, Agapov E, Pierce RA et al. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis 2005; 192: 1052 30 Wyde PR, Chetty SN, Jewell AM et al. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 2003; 60: 51 31 Nicholls JM, Poon LL, Lee KC et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361: 1773-1778 32 Chiou HE, Liu CL, Buttrey MJ et al. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. Chest 2005; 128: 263-272 33 Donnelly CA, Ghani AC, Leung GM et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003; 361: 1761-1766 34 Leung GM, Hedley AJ, Ho LM et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 2004; 141: 662-673 35 Robert Koch Institut. SARS-Epidemie im Jahr 2003: Ein Rückblick auf die Aktivitäten des RKI (Teil 1). Epid Bull 2004; 8: 1-8 36 Hung IF, Cheng VC, Wu AK et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 2004; 10: 1550-1557 37 Guery B, Poissy J, el Mansouf L et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013; 381: 2265 38 Assiri A, Al-Tawfiq JA, Al-Rabeeah AA et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13: 752-761 39 Falzarano D, de Wit E, Rasmussen AL et al. Interferon-α2b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 2013; 19: 1313-1317 40 Omrani AS, Saad MM, Baig K et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis 2014; 14: 1090-1095 41 Al-Tawfiq JA, Momattin H, Dib J et al. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis 2014; 20: 42-46 42 Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43: 331 43 Ohori NP, Michaels MG, Jaffe R et al. Adenovirus pneumonia in lung transplant recipients. Hum Pathol 1995; 26: 1073-1079 44 Doan ML, Mallory GB, Kaplan SL et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant 2007; 26: 883-889 45 Ljungman P, Ribaud P, Eyrich M et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003; 31: 481-486 46 Cook CH, Martin LC, Yenchar JK et al. Occult herpes family viral infections are endemic in critically ill surgical patients. J Med Virol 2004; 72: 121-125 47 Bruynseels P, Jorens PG, Demey HE et al. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet 2003; 362: 1536-1541 48 Hunt DP, Muse VV, Pitman MB. Case records of the Massachusetts General Hospital. Case 12-2013. An 18-year-old woman with pulmonary infiltrates and respiratory failure. N Engl J Med 2013; 368: 1537-1534 49 Ong GM, Lowry K, Mahajan S et al. Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit. J Med Virol 2004; 72: 121-125 50 Engelmann I, Gottlieb J, Meier A et al. Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia: results of an outbreak investigation. Crit Care 2007; 11: R119 51 Jaber S, Chanques G, Borry J et al. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 2005; 127: 233-241 52 De Jong MD, Galasso GJ, Gazzard B et al. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 1998; 39: 141-162 53 Kotton CN, Kumar D, Caliendo AM et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89: 779-795 54 Maschmeyer G, Carratalà J, Buchheidt D et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 2015; 26: 21-33 55 Höffken G, Lorenz J, Kern W et al. Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie – Update 2009, S3-Leitlinie der Paul-Ehrlich-Gesellschaft für Chemotherapie, der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, der Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ. Pneumologie 2009; 63: e1-e68 56 Matar LD, McAdams HP, Palmer SM et al. Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. Radiology 1999; 213: 735-742 57 Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 1: 44 58 Rello J, Rodríguez A, Ibañez P et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 2009; 13: R148 59 Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?. Int J Antimicrob Agents 2007; 29: 630-636 60 Goldmann A, Weber-Carstens S, Buchholz U. Bericht vom ARDS-Netzwerk zum Monitoring schwerer Lungenerkrankungen durch Influenza in der Saison 2012/2013. Epidemiologisches Bulletin 2014; 13: 103-106 61 Ranieri VM, Rubenfeld GD, Thompson BT et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526-2533 62 The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308 63 Brower RG, Lanken PM, MacIntyre N et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. NEJM 2004; 351: 327-336 64 Meade MO, Cook DJ, Guyatt GH et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299: 637-645 65 Guérin C, Reignier J, Richard JC et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368: 2159-2168 66 Extracorporeal Life Support Organization (ESLO). ESLO Guidelines for Adult Respiratory Failure. Im Internet: https://www.elso.org/Resources/Guidelines.aspx 67 Richard C, Argaud L, Blet A et al. Extracorporeal life support for patients with acute respiratory distress syndrome: report of a Consensus Conference. Ann Intensive Care 2014; 4: 15 68 Peek GJ, Mugford M, Tiruvoipati R et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363 69 Noah MA, Peek GJ, Finney SJ et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011; 306: 1659-1668
